Scrape SBIR Biotech Award Database for Procurement Intelligence
- Organization
- National Science Foundation SBIR Program
- Sector
- SBIR-funded biotech companies with urgent procurement needs
- Location
- Location unspecified
Source reference
Executive summary
Current state
NSF SBIR Phase I award provides AICONIC BIOSCIENCES with $305,000 non-dilutive funding for gene therapy platform development but creates structural commercial gaps between their $350M revenue projection and the grant's 18-month, vendor-constrained scope.
Market catalyst
NSF publishes complete SBIR award data including abstracts, technical constraints, and contact information, but no one systematically aggregates this data to identify procurement patterns and urgent spending deadlines across hundreds of awardees.
This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.
Field notes
Intelligence ledger
Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.
Sign in to add intelligence or vote on a field note.
Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.